miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

(2013) J H Huh et al.   BRITISH JOURNAL OF CANCER

Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

(2013) Da Yang et al.   CANCER CELL

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells

(2013) Ilenia Pellicciotta et al.   Cancer Cell International

Identification of Circulating MicroRNA Signatures for Breast Cancer Detection

(2013) M. Chan et al.   CLINICAL CANCER RESEARCH

Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient

(2013) Ye-Won Chung et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

(2013) Y Xiang et al.   ONCOGENE

miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1

(2012) X. Zhu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6

(2012) Xiaolan Zhu et al.   FEBS LETTERS

Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel

(2012) D. M. Cittelly et al.   MOLECULAR CANCER THERAPEUTICS

Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells

(2011) C. N. Marconett et al.   CARCINOGENESIS

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer

(2011) Seong O. Suh et al.   CARCINOGENESIS

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer

(2011) Gottfried E. Konecny et al.   CLINICAL CANCER RESEARCH

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

(2011) Benjamin Boyerinas et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance

(2011) G. Ye et al.   JOURNAL OF CELL SCIENCE

miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes

(2011) Yi-Bing Ouyang et al.   MITOCHONDRION

EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet-Promoted Murine Colon Cancer: Role of G1 Regulators

(2011) H. Zhu et al.   MOLECULAR CANCER RESEARCH

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

(2011) Qing Xu et al.   NUCLEIC ACIDS RESEARCH

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1

(2011) William CS Cho et al.   RNA Biology

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene

(2010) Jianjun Zhang et al.   CANCER

Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts

(2010) Sara Previdi et al.   GYNECOLOGIC ONCOLOGY

MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network

(2010) Jianjun Zhang et al.   Molecular Cancer

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1

(2009) Zhongxing Liang et al.   BIOCHEMICAL PHARMACOLOGY

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

(2009) Greg M Arndt et al.   BMC CANCER

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells

(2009) Na Xu et al.   CELL

MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality

(2009) L. Gramantieri et al.   CLINICAL CANCER RESEARCH

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

(2009) Takahiro Ichimi et al.   INTERNATIONAL JOURNAL OF CANCER

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis

(2009) Can-Jie Guo et al.   JOURNAL OF HEPATOLOGY

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

(2008) Hua Zhu et al.   BIOCHEMICAL PHARMACOLOGY

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

(2008) N. Yang et al.   CANCER RESEARCH

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

(2008) H. Yang et al.   CANCER RESEARCH

MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors

(2008) Fernando Colbari Amaral et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line

(2008) K. K. W. To et al.   MOLECULAR AND CELLULAR BIOLOGY